Pola Orbis Holdings (4927) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 May, 2026Executive summary
FY2025 consolidated net sales were ¥170.3 billion, flat year-over-year, with operating income rising 13.6% to ¥15.7 billion, driven by ORBIS growth and expense control.
Ordinary income increased 5.8% to ¥17,022 million, aided by prior-year foreign exchange gains.
Profit attributable to owners of parent grew 2.0% to ¥9,472 million, despite restructuring expenses.
POLA's domestic revenue declined, but the consignment sales channel's decline slowed; overseas, Chinese store closures aimed to improve profitability.
ORBIS saw continued revenue and income growth, led by strategic skincare products and strong direct selling performance.
Financial highlights
Operating income exceeded plan by ¥1.2 billion (up 8.2%), ordinary income by ¥2.3 billion (up 15.8%), and profit attributable to owners by ¥972 million (up 11.4%).
Extraordinary losses increased by ¥2.3 billion, mainly due to the liquidation of Orbis Beijing and structural reform expenses for Jurlique.
Gross profit was ¥138,264 million, with a gross margin of 81.2%.
Net assets at year-end were ¥163,094 million, equity ratio 82.3%.
Dividends per share totaled ¥52.00, with a payout ratio of 123.9%.
Outlook and guidance
FY2026 consolidated net sales are forecast at ¥173.0 billion (up 1.6%), with operating income projected to rise 10.2% to ¥17.3 billion.
Profit attributable to owners is expected to decrease 5% to ¥9.0 billion due to anticipated extraordinary losses from early retirement program costs.
Annual dividend forecast remains at ¥52 per share, with a payout ratio of 127.8%.
Latest events from Pola Orbis Holdings
- Operating income rose 12.3% on cost cuts, but FX losses drove profit down 38.1%.4927
Q2 202513 May 2026 - Net sales and income fell, but profit rose on forex gains; full-year outlook trimmed.4927
Q2 202413 May 2026 - Operating profit up 18.7% and profit attributable to owners up 88.0% despite lower sales.4927
Q1 202613 May 2026 - Sales and profits fell, but domestic growth and ORBIS strength kept full-year outlook steady.4927
Q3 202413 May 2026 - Sales and profits fell in FY2024, but ORBIS grew and FY2025 targets modest recovery.4927
Q4 202413 May 2026 - Operating income rose 23.5% year-over-year, but profit fell 58.1% on forex losses.4927
Q1 202513 May 2026 - Operating income rose 10.5% year-over-year despite flat sales, led by ORBIS and cost controls.4927
Q3 202513 May 2026